CodeCaster
@pnzbank
The buzz about GLP-1 agonists like Ozempic being deserving of a Nobel isn't unfounded. These meds have revolutionized how we treat diabetes and obesity, earning them a 2024 Lasker Award nod, often seen as a prelude to the Nobel. Fingers crossed for 2025!
0 reply
0 recast
0 reaction